Compound information
- Natural Products
- ZC636071
- Molecular Formula
- C15H21NO5
- Molecular Weight
- 295.141972772 g/mol
- Structure
-
- IUPAC Name
- methyl (2S,3S)-3-(benzyloxycarbonylamino)-2-hydroxy-hexanoate
- InChI
- InChI=1S/C15H21NO5/c1-3-7-12(13(17)14(18)20-2)16-15(19)21-10-11-8-5-4-6-9-11/h4-6,8-9,12-13,17H,3,7,10H2,1-2H3,(H,16,19)/t12-,13-/m0/s1
- InChI Key
- SCUKMOKXTDIRDT-STQMWFEESA-N
- SMILES
- CCC[C@H](NC(=O)OCc1ccccc1)[C@H](O)C(=O)OC
- Source
- ZINC000149707530
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 7 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 84.86 Å2 | LogP | 2.351 |
LogS | -2.883 | LogD | 2.508 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.029 | Pgp substrate | 0.029 |
HIA | 0.965 | F20 % | 0.994 |
F30 % | 0.78 | Caco-2 | -4.74 |
MDCK | -4.621 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.018 | PPB | 59.669 |
VD | 0.868 | Fu | 0.542 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.873 | CYP1A2 substrate | 0.683 |
CYP2A6 substrate | 0.561 | CYP2B6 substrate | 0.673 |
CYP2C19 inhibitor | 0.315 | CYP2C19 substrate | 0.963 |
CYP2C8 substrate | 0.793 | CYP2C9 inhibitor | 0.001 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.031 |
CYP2D6 substrate | 0.967 | CYP2E1 substrate | 0.192 |
CYP3A4 inhibitor | 0.028 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.717 | CL | 5.612 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.015 | Hepatotoxicity | 0.874 |
Mutagenicity | 0.025 | Rat Oral Acute Toxicity | 0.005 |
FDAMDD | 0.167 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.011 | Eye Corrosion | 0.029 |
Eye Irritation | 0.463 | Respiratory Toxicity | 0.005 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.84 | IGC50 | 3.004 |
LC50FM | 3.312 | LC50DM | 5.202 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.105 | NR-AR-LBD | 0.218 |
NR-AhR | 0.002 | NR-Aromatase | 0.044 |
NR-ER | 0.303 | NR-ER-LBD | 0.379 |
NR-PPAR-gamma | 0.196 | SR-ARE | 0.078 |
SR-ATAD5 | 0.379 | SR-HSE | 0.197 |
SR-MMP | 0.005 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.